-
S&P 500 Gains and Losses Today: DoorDash Drives Higher on a New Partnership; Bristol-Myers Squibb Stock Falls
14 Nov 2025 22:47 GMT
… Bristol-Myers Squibb ended a clinical trial of an experimental heart medication, and shares … of the drugmaker fell. Shares of a … price target, and shares of the memory chip … ahead of the split. Bristol-Myers Squibb (BMY) stock dropped 4 …
-
What to Expect from Bristol-Myers Squibb's Earnings
29 Oct 2025 14:57 GMT
… release.
Analysts are estimating that Bristol-Myers Squibb will report an earnings per … .00
-3.00
Stock Performance
Shares of Bristol-Myers Squibb were trading at $42 … track all earnings releases for Bristol-Myers Squibb visit their earnings calendar on …
-
CASI Pharmaceuticals Announces Changes in Board Governance
19 Nov 2025 14:54 GMT
… . (acquired by Amgen), GlaxoSmithKline LLC, Bristol-Myers Squibb and ALZA Corp. (acquired by … market price of our ordinary shares; the risk of substantial dilution …
-
Why Top Investors Are Buying Bristol-Myers Squibb Co
14 Oct 2025 00:07 GMT
… .
Bridgewater Associates, LP (Ray Dalio)
Shares: 2,703,724
Change: +362 … Asset Management, LLC (Joel Greenblatt)
Shares: 607,986
Change: +311,033 … reliable, undervalued healthcare name.
Overall, Bristol-Myers Squibb attracted broad-based institutional buying …
-
PGIM Jennison Health Sciences Fund Sold its Position in Bristol-Myers Squibb Co. (BMY) in Q2
25 Sep 2025 14:20 GMT
… Bristol-Myers Squibb Company (NYSE:BMY). Headquartered in Princeton, New Jersey, Bristol-Myers Squibb … of Bristol-Myers Squibb Company (NYSE:BMY) was -5.80%, and its shares … position following 1Q earnings." Bristol-Myers Squibb Company’s (BMY) Dividend …
-
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
10 Oct 2025 16:11 GMT
… mentioned Merck, AbbVie, Regeneron and Bristol-Myers Squibb.
Reuters could not independently confirm … U.S. listing of its shares.
“I’d like to think … Pfizer deal boosted pharma sector shares, with Eli Lilly the biggest …
-
Want Decades of Passive Income? Buy This ETF and Hold It Forever (Do so and You'll Quickly Be a Part Owner of Chevron and Lockheed Martin, Among Many Others)
17 Nov 2025 21:30 GMT
… can be deployed into more shares of stock. If you… .28%
Coca-Cola
4.20%
Bristol-Myers Squibb
3.03%
Chevron
4.00% …
-
Peptide Therapeutics Market to Reach USD 81.5 Billion by 2034, Driven by Demand for Targeted and Personalized Medicine
17 Nov 2025 13:00 GMT
… Roche AG, Novartis AG, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd … Roche AG
Novartis AG
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries … wise market breakdowns, regional performance shares, detailed company profiles, annual …
-
Price Over Earnings Overview: Bristol-Myers Squibb
04 Jul 2025 15:19 GMT
Looking into the current session, Bristol-Myers Squibb Inc. BMY shares are trading at $47 … ;s price-to-earnings ratio.
Bristol-Myers Squibb P/E Ratio Analysis … .41 in the Pharmaceuticals industry, Bristol-Myers Squibb Inc. has a lower P …
-
Biologic Therapeutic Drugs Technology Analysis and Global Market Forecast Report 2024-2025 & 2029 Featuring Key Players - Merck, F. Hoffmann-La Roche, Johnson & Johnson, Pfizer, & Bristol-Myers Squibb - ResearchAndMarkets.com
11 Jun 2025 12:44 GMT
… structure, including companies' market shares and rankings, strategic alliances, M … ., and Bristol-Myers Squibb Co.
Company Profiles
AbbVie Inc.
Amgen Inc.
AstraZeneca
Bristol-Myers Squibb Co …
About
© 1995-2025